Biogen Inc. (BIIB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 25.82B |
| Enterprise Value | 29.76B |
| P/E Ratio | 36.38 |
| PEG Ratio | -0.79 |
| Price/Sales Ratio | 3.07 |
| Price/Book Ratio | 1.62 |
| Enterprise/Revenue | 3.78 |
| Enterprise/EBITDA | 22.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 9.81B |
| Revenue/Share | 67.35 |
| Gross Profit | 6.91B |
| EBITDA | 3.1B |
| Net Income | 1.29B |
| Diluted EPS | 8.83 |
Balance Sheet
| Total Cash | 1.29B |
| Total Cash/Share | 8.7 |
| Total Debt | 8.36B |
| Total Debt/Equity | 0.44 |
| Current Ratio | 1.87 |
| Book Value Per Share | 127.61 |
Price History
| 52-Week Change | 59.76 |
| 52-Week High | 219.72 |
| 52-Week Low | 127 |
| Moving Average 50 Days | 200.8 |
| Moving Average 200 Days | 183.63 |
Statistics
| Average Volume | 1.27M |
| Shares Outstanding | 147.75M |
| % Held by Institutions | 92 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | January 18, 2001 |
AD
